Optimal Measurable Residual Disease Testing for Acute Myeloid Leukemia
This article discusses MRD testing, highlights the challenges in adopting MRD testing in clinical practice, and provides insights into the future of the field.
Source: Surgical Pathology Clinics - Category: Pathology Authors: Wenbin Xiao, Kseniya Petrova-Drus, Mikhail Roshal Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Food and Drug Administration (FDA) | Hematology | Leukemia | Pathology